Details for New Drug Application (NDA): 209310
✉ Email this page to a colleague
The generic ingredient in SINUVA is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 209310
Tradename: | SINUVA |
Applicant: | Intersect Ent Inc |
Ingredient: | mometasone furoate |
Patents: | 13 |
Pharmacology for NDA: 209310
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 209310
Suppliers and Packaging for NDA: 209310
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310 | NDA | Intersect ENT, Inc. | 10599-003 | 10599-003-01 | 1 POUCH in 1 CARTON (10599-003-01) / 1 IMPLANT in 1 POUCH |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | IMPLANT;IMPLANTATION | Strength | 1.35MG | ||||
Approval Date: | Dec 8, 2017 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 24, 2034 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF NASAL POLYPS IN PATIENTS >=18 YEARS OF AGE WHO HAVE HAD ETHMOID SINUS SURGERY USING A CORTICOSTEROID-ELUTING (MOMETASONE FUROATE) IMPLANT | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 3, 2031 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF NASAL POLYPS IN PATIENTS >=18 YEARS OF AGE WHO HAVE HAD ETHMOID SINUS SURGERY USING A CORTICOSTEROID-ELUTING (MOMETASONE FUROATE) IMPLANT | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 13, 2034 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 209310
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription